# Observational Lymphoma, Non-Hodgkin studies: 44 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 44 trials that are observational for Lymphoma, Non-Hodgkin that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lymphoma, Non-Hodgkin studies: 44 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lymphoma-non-hodgkin

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 44
- Recruiting or not yet: 44
- Read on: November 19, 2026

## Trials

The 25 newest of 44, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07941063 | Multimodal Ultrasound for Lymphoma Classification and Treatment Response Prediction | Chinese PLA General Hospital | Observational | Recruiting | Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941063) |
| August 6, 2026 | NCT07750886 | Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) | Natera, Inc. | Observational | Recruiting | Non-Hodgkin Lymphoma, T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, High-Grade B-Cell Lymphoma, Primary Mediastinal... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750886) |
| June 17, 2026 | NCT07652580 | Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma | Henry M. Jackson Foundation for the Advancement of Military Medicine | Observational | Recruiting | Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma, Immune Dysregulation | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652580) |
| May 29, 2026 | NCT07614035 | Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Not yet recruiting | Non-Hodgkin Lymphoma | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614035) |
| April 22, 2026 | NCT07546188 | AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients. | Grand Hôpital de Charleroi | Observational | Recruiting | Lymphoma, Non-Hodgkin, Care Coordination | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546188) |
| January 2, 2026 | NCT07313943 | PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Hodgkin or Non-Hodgkin Lymphoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07313943) |
| November 25, 2025 | NCT07249528 | A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy | Memorial Sloan Kettering Cancer Center | Observational | Recruiting | Non-hodgkin Lymphoma, Multiple Myeloma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249528) |
| March 21, 2025 | NCT06890091 | Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After... | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Fatigue Symptom, Lymphoma Non-Hodgkin, Chimeric Antigen Receptor T-cell Therapy, Adverse Events | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06890091) |
| March 11, 2025 | NCT06870760 | Pre-malignant States to Hematologic Malignancies in Firefighters | Wake Forest University Health Sciences | Observational | Recruiting | Clonal Hematopoiesis of Indeterminate Potential, Monoclonal Gammopathy, Non Hodgkin Lymphoma, Leukemia, Multiple... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06870760) |
| December 6, 2024 | NCT06721598 | An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders | National Research Center for Hematology, Russia | Observational | Not yet recruiting | Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06721598) |
| December 6, 2024 | NCT06720701 | Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's... | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Not yet recruiting | Non-Hodgkin Lymphoma | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06720701) |
| August 27, 2024 | NCT06573099 | A Real-World Study on Extranodal Lymphoma | Ruijin Hospital | Observational | Not yet recruiting | Lymphoma, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Extranodal Lymphoma, Diffuse Large B Cell Lymphoma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06573099) |
| August 7, 2024 | NCT06541327 | Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection | Ruijin Hospital | Observational | Recruiting | Lymphoma, Non-Hodgkin | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06541327) |
| May 17, 2024 | NCT06418204 | Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics | Wake Forest University Health Sciences | Observational | Recruiting | Breast Carcinoma, Colorectal Carcinoma, Lung Non-Small Cell Carcinoma, Melanoma, Non-Hodgkin Lymphoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06418204) |
| April 10, 2024 | NCT06357754 | Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy... | Bristol-Myers Squibb | Observational | Recruiting | Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia, Multiple Myeloma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06357754) |
| January 12, 2024 | NCT06203652 | The Pathogenesis and Prognostic Factors of Lymphoma | Shanghai Zhongshan Hospital | Observational | Recruiting | Lymphoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06203652) |
| November 14, 2023 | NCT06131801 | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06131801) |
| November 3, 2023 | NCT06116110 | Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU | Miltenyi Biomedicine GmbH | Observational | Recruiting | Non Hodgkin Lymphoma, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06116110) |
| September 21, 2023 | NCT06043011 | Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms | iOMEDICO AG | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell... | 2,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06043011) |
| August 23, 2023 | NCT06008691 | A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian... | Fondazione Italiana Linfomi - ETS | Observational | Recruiting | Non-Hodgkin Lymphoma, B-cell | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06008691) |
| June 28, 2023 | NCT05923502 | (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL) | Ruijin Hospital | Observational | Not yet recruiting | Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Richter Syndrome, Marginal Zone Lymphoma... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05923502) |
| May 3, 2023 | NCT05840575 | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively | Copenhagen University Hospital, Rigshospitalet | Observational | Recruiting | Chemotherapy-Related Cognitive Impairment, Chemotherapeutic Toxicity, Chemo-brain, Cancer, Childhood Cancer, Hodgkin... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05840575) |
| February 28, 2023 | NCT05746858 | Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05746858) |
| February 21, 2023 | NCT05735704 | Early Detection and Screening of Hematological Malignancies - SANGUINE | JaxBio Ltd | Observational | Recruiting | Hematologic Malignancy | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05735704) |
| August 29, 2022 | NCT05518851 | TreAtments and outComes in paTients With prImary CutAneous Lymphoma | Peking University First Hospital | Observational | Recruiting | Primary Cutaneous Lymphoma | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05518851) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ruijin Hospital | 3 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| Wake Forest University Health Sciences | 3 |
| National Cancer Institute (NCI) | 3 |
| Stanford University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |
| Chinese PLA General Hospital | 1 |
| Mayo Clinic | 1 |
| Goethe University | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| National Research Center for Hematology, Russia | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| [Miltenyi Biomedicine GmbH](https://specstream.ai/data/clinical-trials/company/miltenyi-biomedicine-gmbh) | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| [Natera, Inc.](https://specstream.ai/data/clinical-trials/company/natera-inc) | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
| Massive Bio, Inc. | 1 |
| JaxBio Ltd | 1 |
| St. Jude Children's Research Hospital | 1 |
| Grand Hôpital de Charleroi | 1 |
| Peking University First Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| Italy | 6 |
| China | 5 |
| Germany | 4 |
| Japan | 2 |
| Puerto Rico | 2 |
| Czechia | 2 |
| Argentina | 1 |
| Australia | 1 |
| Brazil | 1 |
| United Kingdom | 1 |
| Austria | 1 |
| Russia | 1 |
| Switzerland | 1 |
| Greece | 1 |
| Israel | 1 |
| Lithuania | 1 |
| Belgium | 1 |
| Taiwan | 1 |
| Denmark | 1 |
| South Korea | 1 |
| Jamaica | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Steel fabricators in the United States](https://specstream.ai/data/businesses/steel-fabricators/united-states)
- [Masonry contractors in the United States](https://specstream.ai/data/businesses/masonry-contractors/united-states)
- [Eastern European restaurants in the United States](https://specstream.ai/data/businesses/eastern-european-restaurants/united-states)
- [Animation studios in the United States](https://specstream.ai/data/businesses/animation-studios/united-states)
- [Promotional products companies in the United States](https://specstream.ai/data/businesses/promotional-products-companies/united-states)
- [Hostels in the United States](https://specstream.ai/data/businesses/hostels/united-states)
